Jooss Karin
- SEC CIK
- 0001754280
No open-market purchases or sales filed in the past year.
Current role at each company
- FATE Fate Therapeutics IncDirectoras of Jun 15, 2026
- GRTS Gritstone bio, Inc.SEE REMARKSas of May 17, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Jooss Karin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GRTS Gritstone bio, Inc.
SEE REMARKS1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2024 (view filing) | May 16 | 1 day | Jooss KarinSEE REMARKS | SSale | −13.7K | $0.75 | −$10.3K | −2.0%683.5K after |
FATE Fate Therapeutics Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2022 (view filing) | Jun 3 | 3 days | Jooss KarinDirector | SSale | −1.48K | $22.82 | −$33.8K | −55.3%1.20K after |